Double maintains 1 strategies that include ALLO - Allogene Therapeutics, Inc.
Yahoo
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo
Data Highlights Transformative Promise of CAR T in Solid TumorsPhase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% Confirmed Response RateFour of Five Confirmed Responders Remain in Response Including One Ongoing Remission Over 12 Months Robust Expansion, Persistence, and Tumor Infiltration of ALLO-316 Seen with Standard Lymphodepletion, Showcasing Dagger® Tec
SeekingAlpha
Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate its platform. Click here to read.
SeekingAlpha
Allogene Therapeutics continues to advance its pipeline, with notable progress in key clinical trials and upcoming data readouts. Click to read why ALLO is a Buy.
Yahoo
SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will participate in four upcoming investor conferences in May and June. TD Cowen’s 6th Annual Oncology Innovation Summit: Insights for ASCO & EHATuesday, May 279:30AM PT/12:30PM ET Jefferies Global Healthcare ConferenceWednesda
Yahoo
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the publication of two abstracts on the American Society of Clinical Oncology (ASCO) website in advance of the 2025 ASCO Annual Meeting, taking place May 30-June 3 in Chicago, Illinois. An oral presentation will feature ALLO-316, an in
Current Value
$1.181 Year Return
Current Value
$1.181 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -28.53% | $296.79M | 1.43% |
VIXY | -22.90% | $165.69M | 0.85% |
TAIL | -17.89% | $99.76M | 0.59% |
UGA | -10.26% | $72.51M | 0.97% |
IVOL | -7.13% | $351.30M | 1.02% |
BNO | -7.01% | $103.68M | 1% |
DBE | -6.81% | $51.16M | 0.77% |
USO | -6.62% | $1.18B | 0.6% |
STPZ | -6.45% | $450.22M | 0.2% |
USL | -6.15% | $42.26M | 0.85% |
OILK | -5.99% | $71.89M | 0.69% |
CERY | -5.78% | $460.65M | 0.28% |
DBO | -5.64% | $224.00M | 0.77% |
IBMO | -5.64% | $526.04M | 0.18% |
JUCY | -5.45% | $271.76M | 0.6% |
CPER | -5.42% | $209.20M | 0.97% |
COMT | -5.31% | $603.56M | 0.48% |
LDUR | -5.17% | $929.55M | 0.5% |
VTIP | -4.97% | $15.34B | 0.03% |
FMHI | -4.90% | $752.95M | 0.7% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 55.28% | $44.21M | 0.5% |
ARKG | 52.63% | $1.05B | 0.75% |
XBI | 48.44% | $4.95B | 0.35% |
IBB | 43.41% | $5.36B | 0.45% |
PBE | 41.18% | $223.16M | 0.58% |
IWC | 40.85% | $824.65M | 0.6% |
IWO | 37.92% | $11.48B | 0.24% |
FBT | 37.90% | $1.01B | 0.54% |
VTWO | 37.71% | $13.29B | 0.07% |
IWM | 37.69% | $64.00B | 0.19% |
PTH | 37.21% | $100.99M | 0.6% |
BBH | 37.06% | $329.40M | 0.35% |
GSSC | 36.98% | $577.58M | 0.2% |
KJAN | 36.60% | $289.38M | 0.79% |
IWN | 36.57% | $10.89B | 0.24% |
SCHA | 35.34% | $17.26B | 0.04% |
SPSM | 35.08% | $11.28B | 0.03% |
PINK | 34.95% | $133.06M | 0.5% |
KJUL | 34.81% | $120.75M | 0.79% |
PRFZ | 34.77% | $2.34B | 0.34% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRSP | 61.07% | $4.10B | -12.07% | 0.00% |
FATE | 55.24% | $119.22M | -68.29% | 0.00% |
NTLA | 52.23% | $990.25M | -57.28% | 0.00% |
BEAM | 51.54% | $1.69B | -28.30% | 0.00% |
RXRX | 49.81% | $2.04B | -32.93% | 0.00% |
ABCL | 47.04% | $1.08B | +21.96% | 0.00% |
DNLI | 45.83% | $2.05B | -39.28% | 0.00% |
CRBU | 45.73% | $117.19M | -23.17% | 0.00% |
ARCT | 43.60% | $361.52M | -45.26% | 0.00% |
PACB | 43.52% | $387.11M | -5.84% | 0.00% |
MGNX | 42.92% | $75.08M | -72.00% | 0.00% |
MRNA | 42.48% | $10.50B | -77.13% | 0.00% |
EYPT | 41.45% | $663.34M | +10.80% | 0.00% |
ELME | 41.31% | $1.41B | +0.69% | 4.51% |
VRDN | 40.41% | $1.17B | +10.15% | 0.00% |
UDMY | 40.33% | $1.05B | -18.54% | 0.00% |
GT | 40.27% | $3.06B | -5.55% | 0.00% |
RGNX | 40.23% | $422.76M | -28.29% | 0.00% |
AUTL | 39.13% | $614.79M | -33.62% | 0.00% |
EDIT | 38.96% | $190.87M | -51.18% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FTSD | 0.03% | $231.79M | 0.25% |
AGGH | -0.09% | $323.99M | 0.29% |
BNDX | -0.10% | $67.37B | 0.07% |
VGSH | -0.11% | $22.80B | 0.03% |
FLDR | -0.12% | $944.21M | 0.15% |
STXT | -0.13% | $129.73M | 0.49% |
BSMR | 0.16% | $255.35M | 0.18% |
YEAR | -0.17% | $1.45B | 0.25% |
TLH | -0.18% | $11.46B | 0.15% |
SHY | -0.24% | $24.08B | 0.15% |
BKAG | 0.30% | $1.90B | 0% |
IAGG | 0.30% | $10.42B | 0.07% |
FMB | -0.31% | $1.90B | 0.65% |
NYF | 0.35% | $890.51M | 0.25% |
SHYD | -0.38% | $331.88M | 0.35% |
EUSB | -0.42% | $732.60M | 0.12% |
TLT | -0.47% | $48.88B | 0.15% |
CMDY | 0.49% | $267.79M | 0.28% |
FXC | 0.52% | $92.55M | 0.4% |
VRIG | 0.57% | $1.20B | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -11.65% | $23.98B | +34.66% | 1.10% |
GDDY | -10.69% | $25.66B | +28.89% | 0.00% |
CALM | -10.63% | $5.28B | +62.26% | 6.80% |
INFA | -10.51% | $7.36B | -21.47% | 0.00% |
MSI | -9.44% | $69.88B | +8.45% | 1.01% |
KNOP | -9.35% | $219.16M | -27.14% | 1.64% |
MO | -9.20% | $98.96B | +28.98% | 6.98% |
DOGZ | -8.88% | $363.33M | +65.16% | 0.00% |
TEF | -8.70% | $29.29B | +23.28% | 6.30% |
NOC | -8.64% | $71.10B | +13.32% | 1.72% |
IFRX | -8.57% | $54.23M | -53.57% | 0.00% |
CME | -7.56% | $99.01B | +39.76% | 3.87% |
HUSA | -7.38% | $22.94M | -6.82% | 0.00% |
WDS | -6.76% | $29.23B | -18.02% | 7.90% |
ENB | -6.69% | $97.63B | +25.82% | 5.96% |
LPTH | -6.01% | $129.98M | +140.48% | 0.00% |
BTI | -5.62% | $102.80B | +51.83% | 8.07% |
BTCT | -5.44% | $18.98M | +37.85% | 0.00% |
EDSA | -5.42% | $14.40M | -52.10% | 0.00% |
ACI | -5.34% | $11.95B | +7.29% | 2.54% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TRI | -<0.01% | $89.16B | +17.42% | 0.87% |
FTS | 0.04% | $23.66B | +21.42% | 3.69% |
EE | 0.04% | $943.59M | +59.92% | 0.70% |
TTE | 0.05% | $137.25B | -7.77% | 5.73% |
XOS | 0.08% | $25.10M | -56.30% | 0.00% |
LTM | 0.08% | $12.12B | -95.54% | 2.48% |
PGR | 0.14% | $154.76B | +27.10% | 1.86% |
QNTM | -0.15% | $58.88M | +106.27% | 0.00% |
KR | -0.17% | $47.56B | +43.04% | 1.79% |
D | 0.19% | $47.65B | +14.02% | 4.81% |
SRRK | 0.27% | $3.40B | +329.89% | 0.00% |
CTRE | 0.28% | $5.87B | +21.91% | 3.97% |
PHYS.U | 0.32% | - | - | 0.00% |
CLMT | 0.38% | $1.35B | -3.24% | 0.00% |
GORV | 0.38% | $25.03M | -91.07% | 0.00% |
SYPR | -0.41% | $52.86M | +19.79% | 0.00% |
ENIC | 0.44% | $4.99B | +34.67% | 0.21% |
AMT | -0.44% | $101.95B | +12.04% | 3.05% |
AGI | 0.58% | $10.76B | +63.20% | 0.39% |
XPOF | 0.63% | $265.44M | -51.28% | 0.00% |